Efficacy News and Research

RSS
Drug company payments to doctors: Continuing controversy

Drug company payments to doctors: Continuing controversy

Risks and benefits of anti-aging hormones

Risks and benefits of anti-aging hormones

Alkermes submits VIVITROL sNDA for opioid dependence

Alkermes submits VIVITROL sNDA for opioid dependence

SRI/Surgical Express announces sponsorship of Practice Greenhealth's Greening the OR Symposium

SRI/Surgical Express announces sponsorship of Practice Greenhealth's Greening the OR Symposium

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

Clinical trial data on AMPYRA Extended Release Tablets to be presented at AAN Annual meeting

Clinical trial data on AMPYRA Extended Release Tablets to be presented at AAN Annual meeting

Immunomedics' progress in cancer therapy product candidates to be presented at AACR 2010

Immunomedics' progress in cancer therapy product candidates to be presented at AACR 2010

Investment report on Rexahn Pharmaceuticals

Investment report on Rexahn Pharmaceuticals

Copaxone achieves one million patient years of experience in treatment of RRMS

Copaxone achieves one million patient years of experience in treatment of RRMS

Research finding suggests HCV interference with hepcidin synthesis

Research finding suggests HCV interference with hepcidin synthesis

MS drug TYSABRI to be highlighted at 62nd AAN Annual Meeting

MS drug TYSABRI to be highlighted at 62nd AAN Annual Meeting

Vitamins touted in skin care products reduce signs of sun-damaged skin: Study

Vitamins touted in skin care products reduce signs of sun-damaged skin: Study

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

Research on efficacy of yoga in breast cancer treatment attracts award of over $4.5M

Research on efficacy of yoga in breast cancer treatment attracts award of over $4.5M

Decrease in manic symptoms severity influences prescribing decisions for bipolar mania

Decrease in manic symptoms severity influences prescribing decisions for bipolar mania

Gilead Sciences doses first patient in Quad Phase III clinical program

Gilead Sciences doses first patient in Quad Phase III clinical program

Despite international guidelines, wide variations exist in breast cancer care

Despite international guidelines, wide variations exist in breast cancer care

Pancreaze Delayed Release Capsules receive FDA approval

Pancreaze Delayed Release Capsules receive FDA approval

Researchers evaluate new treatment for coronary heart disease

Researchers evaluate new treatment for coronary heart disease

Angiochem to highlight oncology program data at 101st American Association for Cancer Research meeting

Angiochem to highlight oncology program data at 101st American Association for Cancer Research meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.